FDA
-
-
-
-
-
-
-
Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer
-
-
-
-
-
-
-
Pre-Open Movers 10/30: (CAA) (ADMS) (DYN) Higher; (PSTI) (CTB) (CENX) Lower (more...)
-
-
-
-
-
-
-
Advanced Accelerator Applications and FUJIFILM RI Pharma, Co., LTD Announce First Patient in Bridging Study in Japan for Lutetium Lu 177 Dotatate* (Lutathera®)
-
-
-
-
-
-
-
Advanced Accelerator Applications (AAAP) Announces Positive CHMP Opinion Recommending Approval of Lutetium 177Lu Oxodotreotide for GEP-NET Tumors
-
-
-
-
-
-
-
Advanced Accelerator Applications (AAAP) Agrees to Supply University of Missouri with Lutetium 177
-
-
-
-
-
-
-
Advanced Accelerator Applications CEO Provides Progress Report on Corporate Developments of 2016; Asserts Confidence in Ability to Address FDA Comments on Lutathera® NDA
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

